Trials / Completed
CompletedNCT02535195
Effect of Ginger Supplement on Non-alcoholic Fatty Liver
- Status
- Completed
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- Dr Azita Hekmatdoost · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Accepted
Summary
The hypothesis of this study was that ginger supplement consumption can be introduced as a new therapeutic strategy for non-alcoholic fatty liver disease through the improved body antioxidant activity, reduced levels of inflammation and insulin resistance. A randomized double-blind study was designed to evaluate this hypothesis in order to examine the effectiveness of ginger supplement in patients with non-alcoholic fatty liver disease.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Ginger supplement | |
| DIETARY_SUPPLEMENT | Placebo (starch) |
Timeline
- Start date
- 2013-03-01
- Primary completion
- 2014-02-01
- Completion
- 2015-08-01
- First posted
- 2015-08-28
- Last updated
- 2015-08-28
Source: ClinicalTrials.gov record NCT02535195. Inclusion in this directory is not an endorsement.